Gebro Broschek GmbH, A-6391, Fieberbrunn.
Inflammopharmacology. 1998;6(1):75-9. doi: 10.1007/s10787-998-0008-2.
S(+)-ibuprofen (dexibuprofen) is an NSAID offering a lot of advantages in the treatment of rheumatism and pain. A randomized double-blind, parallel group study in 110 patients showed equivalence in efficacy of 900 mg dexibuprofen (Seractil 300 mg, Gebro Fieberbrunn, Austria) vs. 150 mg diclofenac sodium. Regarding tolerance there was a trend to superiority of dexibuprofen. Therefore dexibuprofen can be characterized as an effective and very tolerable drug against inflammation and pain.
(+)-布洛芬(右旋布洛芬)是一种 NSAID,在治疗风湿病和疼痛方面具有许多优势。一项纳入 110 例患者的随机、双盲、平行分组研究显示,900mg 右旋布洛芬(Seractil 300mg,Gebro Fieberbrunn,奥地利)与 150mg 双氯芬酸钠的疗效相当。关于耐受性,右旋布洛芬有优势的趋势。因此,右旋布洛芬可以被描述为一种有效且非常耐受的抗炎和止痛药物。